Pharmaceutical Nanotechnology Laboratories

Projects

Research grants and awards held in the PNT Lab, from European consortia to translational seed funding.

Current projects

2026–2030

EUzymat – Eutectozymes as innovative antioxidant materials for biomedical applications

European Commission, Marie Skłodowska-Curie Actions Staff Exchanges (HORIZON-MSCA-2026-SE-01) · €173K

A four-year international staff-exchange programme developing eutectic-solvent-based enzyme-mimicking (eutectozyme) antioxidant materials for biomedical use.

PI
2026

Evaluating therapeutic response in adult and paediatric brain cancers using patient-derived 3D tumour models

Industrial Biotechnology Innovation Catalyst (IBIC) · £35K

Extends the lab's nanomedicine platform into patient-derived paediatric brain-tumour models.

PI
2026

MyExoFat – Patient-derived micro-fragmented adipose tissue (MFAT) exosomes as drug delivery vehicles for glioblastoma

Confidence for Translation (C4T) Award, Translation Manchester / MRC · £75K

Translational development of adipose-tissue-derived exosomes as carriers for localised glioblastoma therapy.

PI
2026

In-situ forming peptide-based subcutaneous solid depot for long-term delivery of cancer drugs

Industrial Biotechnology Innovation Catalyst (IBIC) · £76K

The lab leads the in vitro assessment of the developed long-acting depots.

Co-I
2025–2026

Alginate-based hydrogels for complex 3D scaffolds with biochemical, mechanical and physiological relevance

UoM EPSRC Postdoctoral Pathway Fellowship 2025/26 (Fellow: Dr Rebekah Kay) · £59.5K

An externally funded, independent early-career fellowship hosted in the PNT Lab.

PI / host
2024–

HALo – EPSRC National Hub for Advanced Long-Acting Therapeutics (Healthcare Technologies theme)

EPSRC · £10M national Hub, £1.56M at UoM

The lab leads the development and characterisation of in vitro fluidic models for long-acting therapeutics.

Co-I · workstream lead

Previous projects

2025

Cell membrane-derived nanoparticles delivering nucleic acids for pre-eclampsia

Manchester–Melbourne–Toronto Research Fund (UoM) · £9K

A three-continent collaboration that delivered a placenta-on-a-chip model.

Co-I
2024

CD200-engineered microglial nanoparticles encapsulating IKK-16 for glioblastoma therapy

Nuttall Funding Award, Geoffrey Jefferson Brain Research Centre (UoM) · £25K

Established testing of the lab's nanotherapeutics on human patient tissue with the Division of Neuroscience.

Co-I
2024

Upcycling fat tissue for localised glioblastoma treatment

Drug Discovery & Advanced Therapeutics Innovation Lab Award, Wellcome Trust & NIHR via Translation Manchester · £20K

Seed project that generated the preliminary data behind the MyExoFat C4T award.

PI
2023

Reprogramming glioblastoma’s microenvironment using bio-membrane engineered nano-modulators

Royal Society Research Grant · £44K

The lab's first externally peer-reviewed award as an independent group; equipped the core of the laboratory.

PI

Earlier awards & fellowships

Junior Leader Postdoctoral Fellowship

"la Caixa" Foundation

Competitive European postdoctoral fellowship supporting independent research in nanomedicine.

Fellow

Seal of Excellence

European Commission

Awarded to a highly rated proposal submitted to a Horizon Europe call.

Applicant